Register companies, GST & more
AI, Blockchain & Cloud

Biotechnology Industry Partnership Programme (BIPP) cost-sharing grant up to ₹5 Crore+ for high-risk industrial biotech R&D
Industrial Biotech R&D Grant
30% - 50% govt grant assistance
Startups, SMEs & large biotech firms
Novel drugs, vaccines, biologics
Govt of India
The Biotechnology Industry Partnership Programme (BIPP) is a government partnership initiative managed by BIRAC, Department of Biotechnology (DBT), Government of India.
Specifically engineered to support high-risk, high-reward, transformational industrial biotechnology R&D, BIPP provides substantial cost-sharing non-dilutive grant-in-aid of up to 30% to 50% of total project costs (frequently scaling up to ₹5 Crores to ₹10 Crores) to Indian biotech companies.
The program focuses on globally competitive indigenous technological breakthroughs, including novel biopharmaceuticals, recombinant vaccines, cell & gene therapies, industrial synthetic biology, molecular breeding, and advanced medical diagnostics.
By de-risking capital-intensive phase-I/II clinical trials, pilot bio-manufacturing plants, and advanced mammalian cell line development, BIPP has catalyzed several of India's most celebrated indigenous vaccines and biotherapeutic approvals.
Large-scale financial assistance of up to ₹5-10 Crores covering 30% to 50% of total industrial project costs.
Dedicated to frontier discoveries like CRISPR gene editing, mRNA platforms, and monoclonal antibodies.
Substantial capital allocations for human clinical trials, toxicology, and cGMP pilot manufacturing.
Indian commercial enterprises retain 100% ownership and global commercial rights to developed IP.
Steered by apex Project Monitoring Committees comprising India's most eminent biopharma scientists.
Assistance in navigating CDSCO, US FDA, and EMA regulatory compliance pathways.
Public or Private Limited Companies registered under the Indian Companies Act with DSIR-recognized in-house R&D units.
At least 51% of equity shareholding must be owned by Indian resident citizens (or Indian management control).
Must have established laboratory infrastructure, qualified scientific manpower, and proven research capability.
Must be willing to commit matching co-funding (50% to 70% of total project expenditure).
Consortium proposals of Indian companies with premier academic institutions or other companies are eligible.
The proposed technology must address a major unmet medical, agricultural, or industrial priority.
Multi-crore non-dilutive capital to de-risk high-stakes clinical and biological discovery pipelines.
Accelerates transition from early laboratory discovery to multi-million-dollar commercial drugs and vaccines.
Zero equity dilution, preserving full enterprise value and corporate governance independence.
Pre-vetted clinical credibility for securing international pharmaceutical licensing partnerships.
Direct guidance from apex national regulatory authorities and principal clinical investigators.
Elevates the company into India's premier tier of biopharmaceutical innovation leaders.
Certificate of Incorporation, MoA / AoA, and Indian Shareholding Certificate (CA Certified).
DSIR In-House R&D Recognition Certificate (or proof of application).
Comprehensive BIPP Technical Proposal with molecular data, target validation, and clinical plan.
Detailed Itemized Project Budget with matching promoter co-funding commitment.
Audited Financial Statements for the preceding 3 financial years.
Statutory Clearances (IBSC, RCGM, CDSCO CT NOC if applicable).
Company Bank Account Details & Cancelled Cheque.
Five stages, one record of every startup we've moved forward
Served
0+
Startups nationwide
Save up to 100%
on eligible startup taxes
Satisfaction score
0%
rated by founders we've worked with
Client outcomes
0%
of Technocrat clients reach the interview stage with investors
Certified
0+
Startups registered
Startup India
Certificate
Total disbursed
₹0+ Cr
disbursed to
0+
businesses, and counting
0+
Businesses granted a 3-year tax holiday
Funding
Guide 2025
Director · Shri Giriraj Dharan company
A highly professional consulting and IT company offering reliable solutions, excellent customer service, and skilled experts. They deliver quality work efficiently, maintain clear communication, and consistently exceed client expectations.
owner · om glass fibre
Excellent consulting and IT company with professional staff, innovative solutions, and reliable support. Their team understands client needs, delivers projects on time, communicates clearly, and provides outstanding service throughout every engagement.
Find answers to the most common questions about our services. Contact us if you need more personalized support.
Have questions about our business consultation, tech solutions, or startup programs? Get in touch with our team today.
Fill out the form below and our consulting lead will respond within 24 hours.